Cyndi Shannon Weickertprofile image
Professor

Cyndi Shannon Weickert


Current Appointments

NSW Chair of Schizophrenia Research
Professor, School of Psychiatry, UNSW Professor, Department of Neuroscience and Physiology, Upstate Medical University, New York
email hidden; JavaScript is required

Cyndi’s research is focused on the molecular developmental neurobiology of schizophrenia. She earned a PhD in Biomedical Science at Mount Sinai School of Medicine, New York City and completed postdoctoral training at the National Institute of Mental Health rising to the level of Unit Chief of Molecules in the Neurobiology and Development of Schizophrenia Unit. Her awards include the Eli Lilly Young Investigator Award, NIH Fellows Award for Research Excellence, Independent Investigator Award and two Young Investigator Awards from NARSD. She has lectured throughout the world and contributed to over 150 publications.

My research has several aims:

  • To determine the neurobiological underpinning of psychiatric diseases in order to develop more effective treatments.
  • To identify biological subgroups of people with schizophrenia based on inflammation.  To determine if these subgroups cut across schizophrenia, bipolar and depression.
  • To use knowledge gained on neuroinflammation subgroups in major psychiatric disorders to inform the development of biologically informed treatments (or more individualised treatments).
  • To understand how the balance between factors that damage brain cells verses factors that repair and regenerate brain cells differ in psychiatric conditions.

Publications

2018, 01 Feb

Considering the role of adolescent sex steroids in schizophrenia.

View full journal-article on http://europepmc.org/abstract/med/28941299

2017 Sep

Lower antioxidant capacity in the prefrontal cortex of individuals with schizophrenia.

View full journal-article on http://europepmc.org/abstract/med/28891319

2017 Aug

Decreased Brain pH as a Shared Endophenotype of Psychiatric Disorders.

View full journal-article on http://europepmc.org/abstract/med/28776581

2017 Aug

Neuregulin-1 (NRG1) polymorphisms linked with psychosis transition are associated with enlarged lateral ventricles and white matter disruption in schizophrenia.

View full journal-article on http://europepmc.org/abstract/med/28826413

2017 Aug

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.

View full journal-article on http://europepmc.org/abstract/med/28850113

2017

Accelerated gray and white matter deterioration with age in schizophrenia

View full journal-article on http://www.scopus.com/inward/record.url?eid=2-s2.0-85014499765&partnerID=MN8TOARS

2017

Early-life decline in neurogenesis markers and age-related changes of TrkB splice variant expression in the human subependymal zone

View full journal-article on http://www.scopus.com/inward/record.url?eid=2-s2.0-85021918574&partnerID=MN8TOARS

2017

Effects of immune activation during early or late gestation on N-Methyl-D-Aspartate receptor measures in adult rat offspring

View full journal-article on http://www.scopus.com/inward/record.url?eid=2-s2.0-85029668377&partnerID=MN8TOARS

2017

Effects of immune activation during early or late gestation on schizophrenia-related behaviour in adult rat offspring

View full journal-article on http://www.scopus.com/inward/record.url?eid=2-s2.0-85008323025&partnerID=MN8TOARS

2017

Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markers

View full journal-article on http://www.scopus.com/inward/record.url?eid=2-s2.0-85026651108&partnerID=MN8TOARS